查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1661630

美國的神經血管栓塞設備市場評估:各產品，疾病病理，各終端用戶，各地區，機會，機會及預測，2018～2032年

United States Neurovascular Embolization Devices Market Assessment, By Product, By Disease Pathology, By End Use, By Region, Opportunities, and Forecast, 2018-2032F
出版日期: | 出版商: Market Xcel - Markets and Data | 英文 131 Pages | 商品交期: 3-5個工作天內

價格

美國醫療保健服務和保險覆蓋範圍的改善為治療神經血管患者提供了更強大的基礎設施。預計 2024 年美國神經栓塞設備市場價值將達到 3.862 億美元，預計 2025 年至 2032 年期間的複合年增長率為 8.51%。由於久坐的生活方式導致腦動脈出血和異常盛行率上升、腦動脈瘤和動靜脈畸形 (AVM) 病例增加是神經血管栓塞裝置需求激增的主要原因。此外，推動美國神經栓塞設備市場成長的因素包括老年人口的增加、高血壓患者數量的增加以及新型神經栓塞設備的引入。

稱為神經栓塞裝置的血管內植入物旨在永久切斷腦動脈瘤和動靜脈畸形的血液供應。

目錄

第1章 調查手法

第2章 計劃的範圍和定義

第3章 摘要整理

第4章 美國的神經血管栓塞設備市場展望，2018年～2032年

  • 市場規模與預測
    • 各金額
    • 各數量
  • 市場佔有率與預測
    • 各產品
      • 動脈瘤夾
      • 液體栓塞系統
      • 栓塞線圈
      • 血流轉換支架
      • 囊內血流阻礙要素
    • 疾病病理
      • 缺血性中風
      • 腦動脈瘤
      • 頸動脈狹窄症
      • 動靜脈畸形及瘺管
      • 其他的病
    • 各終端用戶
      • 醫院
      • 門診病人手術中心
      • 專門診所
      • 其他
    • 地區
      • 東北部
      • 西南部
      • 西部
      • 東南部
      • 中西部
    • 市場佔有率(%)各企業，2024年

第5章 市場製圖，2024年

  • 各產品
  • 疾病病理
  • 各終端用戶
  • 各地區

第6章 宏觀環境和產業結構

  • 供給需求分析
  • 進口出口分析
  • 價值鏈分析
  • 神經血管栓塞設備市場PESTEL分析
    • 政治要素
    • 經濟系統
    • 社會影響
    • 技術的進步
    • 對環境的影響
    • 法律合規與監管政策（包括法定機構）
  • 波特的五力分析
    • 供應商的力量
    • 買方勢力
    • 替代威脅
    • 新加入廠商的威脅
    • 競爭企業間的敵對關係

第7章 市場動態

  • 成長促進因素
  • 阻礙成長的要素

第8章 法規結構和革新

  • 臨床試驗
  • 專利形勢
  • FDA核准
  • 產品革新/新興技術

第9章 案例研究

第10章 價格分析

第11章 主要企業的形勢

  • 市場領導前五名公司的競爭矩陣
  • 前五名市場領導的市場收益分析(%、2024年)
  • 併購/合資（如適用）
  • SWOT 分析（針對 5 家市場公司）

第12章 主要企業的展望

  • Microport Scientific Corporation
    • 公司概要
    • 主要經營團隊
    • 產品和服務
    • 財務狀況(如報告)
    • 主要市場的著重和地理存在感
    • 最近的趨勢
  • Integra LifeSciences Corporation
  • Medtronic Plc
  • Terumo Corporation(MicroVention, Inc)
  • B. Braun Melsungen AG
  • Penumbra, Inc
  • Stryker Corporation
  • Kaneka Medical Products
  • Johnson &Johnson(Cerenovous)
  • Codman &Shrutleff, Inc.

上述公司尚未根據市場佔有率保留訂單，並且可能根據研究工作期間可用的資訊而發生變化。

第14章 策略性建議

第15章 關於調查公司·免責聲明

Product Code: MX10061

Improved access to healthcare services and insurance coverage in the United States have resulted in a more robust infrastructure for treatment of neurovascular patients. The United States Neurovascular Embolization Devices market was valued at 386.20 million in 2024 and is projected to be growing at a CAGR of 8.51% from 2025 to 2032. The increasing prevalence of hemorrhages & anomalies in cerebral arteries, rising cases of brain aneurysms, and arteriovenous malformations (AVMs) due to sedentary lifestyles are the main causes of surge in demand for neurovascular embolization devices. In addition, factors driving the growth of the United States neurovascular embolization devices market includes increasing geriatric population, increasing number of patients with hypertension and the introduction of novel neurovascular embolization devices.

An intravascular implant called a neurovascular embolization device is designed to permanently cut off blood supply to brain aneurysms and arteriovenous malformations.

Increasing Number of Patients with Cerebral Aneurysm Driving the Market

In recent years, there has been an increasing number of cerebral aneurysm patients in the United States, which has led to a growing demand for neurovascular embolization devices in the market. The market for these devices has been growing as more patients are diagnosed with cerebral aneurysms and seek treatment. Ruptured brain aneurysm affects around 6.7 million people in the United States, or one in every fifty people. Women above the age 55, have a higher risk of cerebral aneurysm rupture as compared to men.

Technological Advancements Accelerating the Market Growth

Technological advancements have made it possible to identify a size and shape of aneurysm. One major advancement is the development of new materials for embolization coils and flow diverters. These devices are used to block blood flow to abnormal blood vessels in the brain, and the new materials provide better visibility and control during the procedure. Additionally, there has been increased use of robotic systems for neurovascular procedures, which provide greater precision and control during the procedure.

Increasing Research Activities Support Market Expansion

The continuous emphasis on research activities has resulted in the creation of more sophisticated embolization devices, such as flow-diverting stents and liquid embolics, that have made the treatment of aneurysms and arteriovenous malformations more accessible. This improves the outcomes of the patients and enhances the success rate of neurovascular interventions. Increased investments in research enables a higher number of clinical trials and thus accelerates the regulatory approval process for new devices. Additionally, by focusing on research activities, medical technology companies are also able to ensure the development and availability of advanced technologies for effective management and treatment of chronic conditions.

For instance, in January 2023, Fluidx Medical Technology, Inc. release findings from their in vivo research for the Impass embolic device for middle meningeal artery (MMA) embolization for treating chronic subdural hematomas on the brain's surface. The device utilizes a low-viscosity, aqueous-based solution that solidifies into a durable embolus upon delivery. This technology aims to improve safety and efficacy during embolization procedures, potentially leading to better patient outcomes and increased adoption by healthcare providers, thus, supporting the market's expansion.

Cerebral Embolization and Aneurysm Coiling Devices Account for Majority of Market Share

Cerebral embolization and aneurysm coiling devices led the neurovascular device market. More than 40% of the market was accounted for cerebral embolization and aneurysm coiling devices, which are widely used in the treatment of aneurysms and strokes. Rising healthcare costs, increased R&D spending, and rising frequency of neurological diseases such as brain aneurysms, stroke, and arteriovenous malformations (AVMs) are few factors driving the market expansion.

Impact of COVID-19 on the United States Neurovascular Embolization Devices Market

The pandemic had a significant impact on the United States Neurovascular Embolization Device Market. The market has witnessed a decline in growth due to the pandemic's impact on healthcare facilities' operations, as well as a reduction in demand for non-urgent medical procedures. Additionally, the disruption of supply chains caused by the pandemic has led to delays in the production and distribution of neurovascular embolization devices, further impacting the market's growth. The market bounced back to pre-pandemic levels after upliftment of lockdown.

Impact of Russia-Ukraine War on the United States Neurovascular Embolization Devices Market

The Russia-Ukraine war did not have a significant impact on the United States neurovascular embolization market. Although, the war disrupted the trade dynamics such as demand-supply, pricing variances, impact on import/export and trading activities between United States, Russia, and Ukraine. Economic sanctions imposed by United States impacted the export of devices to Russia.

Key Players Landscape and Outlook

The market for neurovascular devices is competitive and is dominated by major players. The key players in the market are Terumo Corporation, Johnson & Johnson, and Medtronic Plc, Microport Scientific Corporation, Integra Life Sciences Corporation, Penumbra Inc and many others.

In 2021, Medtronic recalled two of its transcatheter devices intended to seal brain aneurysms: the Pipeline Flex Embolization Device and the Pipeline Flex Embolization Device with Shield Technology. The wire and tubes fractured and broke down when the delivery systems were used to place, remove, or relocate the stent within a patient.

Table of Contents

1. Research Methodology

2. Project Scope & Definitions

3. Executive Summary

4. United States Neurovascular Embolization Devices Market Outlook, 2018-2032F

  • 4.1. Market Size & Forecast
    • 4.1.1. By Value
    • 4.1.2. By Volume
  • 4.2. Market Share & Forecast
    • 4.2.1. By Product
      • 4.2.1.1. Aneurysm Clips
      • 4.2.1.2. Liquid Embolic Systems
      • 4.2.1.3. Embolization Coils
      • 4.2.1.4. Flow Diversion Stents
      • 4.2.1.5. Intrasaccular Flow Disruptors
    • 4.2.2. By Disease Pathology
      • 4.2.2.1. Ischemic Strokes
      • 4.2.2.2. Cerebral Aneurysm
      • 4.2.2.3. Carotid Artery Stenosis
      • 4.2.2.4. Arteriovenous Malformations and fistulas
      • 4.2.2.5. Other Diseases
    • 4.2.3. By End User
      • 4.2.3.1. Hospitals
      • 4.2.3.2. Ambulatory Surgical Centers
      • 4.2.3.3. Specialty Clinics
      • 4.2.3.4. Others
    • 4.2.4. Region
      • 4.2.4.1. Northeast
      • 4.2.4.2. Southwest
      • 4.2.4.3. West
      • 4.2.4.4. Southeast
      • 4.2.4.5. Midwest
    • 4.2.5. By Company Market Share (%), 2024

5. Market Mapping, 2024

  • 5.1. By Product
  • 5.2. By Disease Pathology
  • 5.3. By End User
  • 5.4. By Region

6. Macro Environment and Industry Structure

  • 6.1. Supply Demand Analysis
  • 6.2. Import Export Analysis
  • 6.3. Value Chain Analysis
  • 6.4. PESTEL Analysis of the Neurovascular Embolization Devices Market
    • 6.4.1. Political Factors
    • 6.4.2. Economic System
    • 6.4.3. Social Implications
    • 6.4.4. Technological Advancements
    • 6.4.5. Environmental Impacts
    • 6.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
  • 6.5. Porter's Five Forces Analysis
    • 6.5.1. Supplier Power
    • 6.5.2. Buyer Power
    • 6.5.3. Substitution Threat
    • 6.5.4. Threat from New Entrant
    • 6.5.5. Competitive Rivalry

7. Market Dynamics

  • 7.1. Growth Drivers
  • 7.2. Growth Inhibitors

8. Regulatory Framework and Innovation

  • 8.1. Clinical Trials
  • 8.2. Patent Landscape
  • 8.3. FDA Approvals
  • 8.4. Product Innovations/Emerging Technologies

9. Case Studies

10. Pricing Analysis

11. Key Players Landscape

  • 11.1. Competition Matrix of Top Five Market Leaders
  • 11.2. Market Revenue Analysis of Top Five Market Leaders (in %, 2024)
  • 11.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
  • 11.4. SWOT Analysis (For Five Market Players)

12. Key Players Outlook

  • 12.1. Microport Scientific Corporation
    • 12.1.1. Company Details
    • 12.1.2. Key Management Personnel
    • 12.1.3. Products & Services
    • 12.1.4. Financials (As reported)
    • 12.1.5. Key Market Focus & Geographical Presence
    • 12.1.6. Recent Developments
  • 12.2. Integra LifeSciences Corporation
  • 12.3. Medtronic Plc
  • 12.4. Terumo Corporation (MicroVention, Inc)
  • 12.5. B. Braun Melsungen AG
  • 12.6. Penumbra, Inc
  • 12.7. Stryker Corporation
  • 12.8. Kaneka Medical Products
  • 12.9. Johnson & Johnson (Cerenovous)
  • 12.10. Codman & Shrutleff, Inc.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work

14. Strategic Recommendations

15. About Us & Disclaimer

List of Tables

  • Table 1. Competition Matrix of Top 5 Market Leaders
  • Table 2. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 3. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. United States Neurovascular Embolization Devices Market, By Value, In USD Million, 2018 - 2032F
  • Figure 2. United States Neurovascular Embolization Devices Market, By Volume, In Thousand Units, 2018 - 2032F
  • Figure 3. United States Neurovascular Embolization Devices Market Share, By Product, In USD Million, 2018 - 2032F
  • Figure 4. United States Neurovascular Embolization Devices Market Share, By Product, In Thousand Units, 2018 - 2032F
  • Figure 5. United States Neurovascular Embolization Devices Market Share, By Disease Pathology, In USD Million, 2018 - 2032F
  • Figure 6. United States Neurovascular Embolization Devices Market Share, By Disease Pathology, In Thousand Units, 2018 - 2032F
  • Figure 7. United States Neurovascular Embolization Devices Market Share, By End User, In USD Million, 2018 - 2032F
  • Figure 8. United States Neurovascular Embolization Devices Market Share, By End User, In Thousand Units, 2018 - 2032F
  • Figure 9. United States Neurovascular Embolization Devices Market Share, By Region, In USD Million, 2018 - 2032F
  • Figure 10. United States Neurovascular Embolization Devices Market Share, By Region, In Thousand Units, 2018 - 2032F
  • Figure 11. By Product Map-Market Size (USD Million) & Growth Rate (%), 2024
  • Figure 12. By Disease Pathology Map-Market Size (USD Million) & Growth Rate (%), 2024
  • Figure 13. By End User Map-Market Size (USD Million) & Growth Rate (%), 2024
  • Figure 14. By Region Map-Market Size (USD Million) & Growth Rate (%), 2024